DOI:
10.1055/s-00022861
Aktuelle Kardiologie
LinksClose Window
References
Haude M, Erbel R, Erne P. et al.
Safety and performance of the DRug-Eluting Absorbable Metal Scaffold (DREAMS) in patients with de novo coronary lesions: 3-year results of the prospective, multicentre, first-in-man BIOSOLVE-I trial.
EuroIntervention 2016;
12: e160-e166
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.